A ratio of IGF-I/IGFBP-3 may be more useful in assessing metabolic risk [113], as a low IGF-I/IGFBP-3 ratio is associated with an approximately 3-fold increased likelihood of having the metabolic syndrome in both men and women [114]. This evidence concerns the gene IGF1 and metabolic syndrome.